Wikisage, the free encyclopedia of the second generation, is digital heritage

Brivaracetam

From Wikisage
Jump to navigation Jump to search


4n propyl analog of levetiracetam, this and levetiracetam may have potential in the management of progressive myoclonic epilepsies [1][2]Like levetiracetam (LEV), it is a ligand of the synaptic vesicle protein SV2A[3]

Links

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm486827.htm


An open-label, prospective, exploratory study of patients with epilepsy switching from levetiracetam to brivaracetam


ATC

  • (2S)-2-[(4R)-2-oxo- 4-propylpyrrolidin-1-yl] butanamide

    (2S)-2-[(4R)-2-oxo- 4-propylpyrrolidin-1-yl] butanamide

brivaracetam
[4]


Q408099 at Wikidata  Interwiki via Wikidata


  1. ↑ Profile of brivaracetam and its potential in the treatment of epilepsy
  2. ↑ Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset
  3. ↑ Brivaracetam as adjunctive therapy for the treatment of partial-onset seizures in patients with epilepsy: the current evidence base
  4. ↑ http://www.whocc.no/atc_ddd_index/?code=N03AX23
Retrieved from "https://en.wikisage.org/w/index.php?title=Brivaracetam&oldid=9593"